Kotak Mahindra Advisors Invests INR10.7b (~USD129.4) in India’s Biocon
Source(s): AVCJ
Kotak Mahindra Advisors, the alternative assets arm of Kotak Mahindra Group, invested INR10.7bn (~USD129.4m) in Biocon, an India-based pharmaceuticals manufacturer.